Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
13 p, 1.1 MB Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose / Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Rabe, Klaus F. (Observational and Pragmatic Research Institute) ; Price, David (Universitair Ziekenhuis Gent) ; Brusselle, Guy (National Jewish Health) ; Wechsler, Michael E. (Regeneron Pharmaceuticals Inc.) ; Xia, Changming (Sanofi) ; Pandit-Abid, Nami (Sanofi) ; Gall, Rebecca (Regeneron Pharmaceuticals Inc.) ; Rowe, Paul J. (Sanofi) ; Deniz, Yamo (Regeneron Pharmaceuticals Inc.) ; Jacob-Nara, Juby A. (Sanofi) ; Radwan, Amr (Regeneron Pharmaceuticals Inc.) ; Universitat Autònoma de Barcelona
Dupilumab has been shown to improve clinical outcomes long term while reducing oral corticosteroid (OCS) dose in patients with severe OCS-dependent asthma. This post hoc analysis assesses the impact of OCS dose at baseline (≤10 or >10 mg·day −1) on long-term outcomes of dupilumab treatment. [...]
2023 - 10.1183/23120541.00056-2023
ERJ Open Research, Vol. 9 (november 2023)  
2.
11 p, 2.6 MB Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma / Papi, Alberto (University Hospital) ; Corren, Jonathan (David Geffen School of Medicine at UCLA) ; Castro, Mario (University of Kansas School of Medicine) ; Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Rogers, Linda (Icahn School of Medicine at Mount Sinai) ; Chapman, Kenneth R. (University of Toronto) ; Jackson, Daniel J. (University of Wisconsin School of Medicine and Public Health) ; Daizadeh, Nadia (Sanofi) ; Pandit-Abid, Nami (Sanofi) ; Gall, Rebecca (Regeneron Pharmaceuticals. Inc) ; Jacob-Nara, Juby A. (Sanofi) ; Rowe, Paul J. (Sanofi) ; Deniz, Yamo (Regeneron Pharmaceuticals. Inc) ; Ortiz, Benjamin (Regeneron Pharmaceuticals. Inc) ; Universitat Autònoma de Barcelona
Severe asthma exacerbations increase the risk of accelerated lung function decline. This analysis examined the effect of dupilumab on forced expiratory volume in 1 s (FEV) in patients with moderate-to-severe asthma and elevated type 2 biomarkers from phase 3 LIBERTY ASTHMA QUEST (NCT02414854). [...]
2022 - 10.1111/all.15456
Allergy, Vol. 78 (august 2022) , p. 233-243  
3.
4 p, 302.7 KB Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation / Hanania, Nicola A (Baylor College of Medicine) ; Maspero, Jorge F (Fundación CIDEA) ; Halpin, David M G (University of Exeter) ; Jackson, David J (Guy's Severe Asthma Centre, Guy's and St Thomas' NHS Foundation Trust) ; Panettieri, Reynold A (The State University of New Jersey) ; Castro, Mario (University of Kansas School of Medicine) ; Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Daizadeh, Nadia (Sanofi) ; Gall, Rebecca (Regeneron Pharmaceuticals. Inc) ; Jacob-Nara, Juby A (Sanofi) ; Ortiz, Benjamin (Regeneron Pharmaceuticals. Inc) ; Djandji, Michel (Sanofi) ; Rowe, Paul J (Sanofi) ; Deniz, Yamo (Regeneron Pharmaceuticals. Inc) ; Universitat Autònoma de Barcelona
2022 - 10.2147/JAA.S354013
Journal of Asthma and Allergy, Vol. 15 (june 2022) , p. 851-854  
4.
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma / Papadoppoulos, Nikolaos G. (University of Athens) ; Szefler, Stanley J. (The University of Colorado School of Medicine and Children's Hospital Colorado) ; Bacharier, Leonard B. (Vanderbilt University Medical Center) ; Maspero, Jorge F (Fundación CIDEA, Buenos Aires) ; Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Fiocchi, Alessandro (University of Athens) ; Lee, Jason K. (Toronto Allergy and Asthma Clinic) ; Daizadeh, Nadia (Sanofi, Cambridge (MA)) ; Lederer, David J. (Regeneron Pharmaceuticals. Inc) ; Hardin, Megan (Sanofi, Cambridge (MA)) ; Gall, Rebecca (Regeneron Pharmaceuticals. Inc) ; Djandji, Michel (Sanofi, Cambridge (MA)) ; Siddiqui, Shahid (Regeneron Pharmaceuticals. Inc) ; Jacob-Nara, Juby A (Sanofi, Cambridge (MA)) ; Deniz, Yamo (Regeneron Pharmaceuticals. Inc) ; Rowe, Paul J. (Sanofi, Cambridge (MA))
Wiley-Blackwell, 2023 - 10.1111/all.15743
Allergy  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.